Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements

VANCOUVER, British Columbia, Oct. 31, 2023 -- Mydecine Innovations Group Inc. a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

Related Keywords

Canada ,United Kingdom ,United States ,Vancouver ,British Columbia ,Canadian ,America ,British ,David Coffman George Duxberry ,Joshua Bartch ,Mydecine Innovations Group Inc ,Aquis Stock Exchange ,Opensky Opportunities Fund Ltd ,Mydecine Innovations Group ,Company Final Short Form Base Shelf Prospectus ,Short Form Base Shelf Prospectus ,Health Canada ,Johns Hopkins University ,European Union Withdrawal ,Instagram ,Novum Securities ,Shelf Prospectus ,Twitter ,University Of Alberta ,Linkedin ,Youtube ,Innovations Group ,Common Share Subscription Agreement ,Opensky Opportunities Fund ,Opensky Subscription Agreement ,Final Short Form Base Shelf Prospectus ,Prospectus Supplement ,Subscription Agreements ,Base Shelf Prospectus ,Electronic Document Analysis ,North America ,Applied Pharmaceutical Innovation ,Johns Hopkins ,Market Abuse Regulation ,European Union ,Chief Executive Officer ,Securities Limited ,United States Securities Act ,Pender Street ,Markets ,